Walgreens Boots Alliance, Inc. (WBA) |
|
32.91 -0.5 (-1.5%)
|
03-17 16:00 |
|
Open: |
33.15 |
Pre. Close: |
33.41 |
|
High:
|
33.34 |
Low:
|
32.535 |
|
Volume:
|
17,214,645 |
Market Cap:
|
28,385(M) |
|
|
|
Technical analysis |
as of: 2023-03-20 7:50:54 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 41.31 One year: 43.36 |
| Support: |
Support1: 32.53 Support2: 27.06 |
| Resistance: |
Resistance1: 35.37 Resistance2: 37.13 |
| Pivot: |
34.32 |
| Moving Average: |
MA(5): 33.34 MA(20): 34.79
MA(100): 37.42 MA(250): 38.69 |
| MACD: |
MACD(12,26): -0.9 Signal(9): -0.8 |
| Stochastic oscillator: |
%K(14,3): 17 %D(3): 17.5  |
| RSI: |
RSI(14): 32.4 |
| 52-week: |
High: 48.47 Low: 30.38 |
| Average Vol(K): |
3-Month: 6,618 (K) 10-Days: 8,408 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ WBA ] has closed above bottom band by 15.9%. Bollinger Bands are 11.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
33.38 - 33.59 |
33.59 - 33.74 |
|
Low:
|
32.04 - 32.3 |
32.3 - 32.48 |
|
Close:
|
32.57 - 32.95 |
32.95 - 33.22 |
|
Company Description |
|
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. |
Headline News |
Mon, 20 Mar 2023
Brokerages have given Walgreens Boots Alliance, Inc. (NASDAQ ... - Best Stocks
Sun, 19 Mar 2023
Stephens Inc. AR Has $1.48 Million Stock Holdings in Walgreens ... - MarketBeat
Sat, 18 Mar 2023
Sound Income Strategies LLC Boosts Stake in Walgreens Boots ... - MarketBeat
Sat, 18 Mar 2023
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Given Average ... - MarketBeat
Thu, 16 Mar 2023
Here's Why You Should Retain Walgreens Boots (WBA) For Now - Nasdaq
Mon, 06 Mar 2023
Walgreens Boots Alliance Inc. stock falls Monday, underperforms market - MarketWatch
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Pharmaceutical Retailers |
| Shares Out. |
863 (M) |
| Shares Float |
713 (M) |
|
% Held by Insiders
|
17.1 (%) |
|
% Held by Institutions
|
61.7 (%) |
|
Shares Short
|
31,250 (K) |
|
Shares Short P.Month
|
31,660 (K) |
Stock Financials |
|
EPS
|
-3.37 |
|
EPS Est Next Qtl
|
1.49 |
|
EPS Est This Year
|
5 |
|
EPS Est Next Year
|
6.09 |
|
Book Value (p.s.)
|
23.86 |
|
Profit Margin (%)
|
-2.3 |
|
Operating Margin (%)
|
1.5 |
|
Return on Assets (ttm)
|
1.3 |
|
Return on Equity (ttm)
|
-11.4 |
|
Qtrly Rev. Growth
|
-1.5 |
|
Gross Profit (p.s.)
|
32.77 |
|
Sales Per Share
|
153.25 |
|
EBITDA (p.s.)
|
4.33 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
3,290 (M) |
|
Levered Free Cash Flow
|
4,880 (M) |
Stock Valuations |
|
PE Ratio
|
-9.77 |
|
PEG Ratio
|
1.8 |
|
Price to Book value
|
1.37 |
|
Price to Sales
|
0.21 |
|
Price to Cash Flow
|
8.62 |
Stock Dividends |
|
Dividend
|
0.47 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
1.4% |
|
Dividend Pay Date
|
2021-12-09 |
|
Ex-Dividend Date
|
2021-11-11 |
|
Your Ad Here
|
|
